JEOL stock (JP3612800009): Medical equipment business sale to Sysmex marks strategic shift

Endpoints NewsMacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attack

FierceBiotechCreate Medicines fashions $122M fundraise for in vivo CAR-T dreams

BioPharma DiveWith new data, Regenxbio to seek FDA approval of Duchenne gene therapy

Endpoints NewsHow Penn Medicine plans to use AI to train their doctors

FierceBiotechBiogen advances Alzheimer’s tau program despite midphase miss

BioWorldSanofi synthesizes new ERK5 inhibitors

BioWorldSironax patents new SARM1 inhibitors

BioWorldPfizer discloses new dual calcitonin/amylin receptor agonists

BioWorldLoss of androgens tied to faster glioblastoma growth

PharmaVoiceFDA chief’s exit clouds already murky drug approvals

JEOLJEOL stock (JP3612800009): Medical equipment business sale to Sysmex marks strategic shift - AD HOC NEWS

Endpoints NewsBiogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy